SYNTARA LIMITED - Announcements

Market Cap $28.65M Add to my watchlist

Healthcare

Syntara Limited, formerly Pharmaxis Ltd, is an Australia-based clinical-stage drug... Syntara Limited, formerly Pharmaxis Ltd, is an Australia-based clinical-stage drug development company with a focus on blood-related cancers. The Company’s highly productive drug discovery engine is driven by its expertise in amine oxidase inhibitors. Its lead candidate, PXS-5505, is used for the bone marrow cancer myelofibrosis, which causes a build-up of scar tissue that leads to loss of red and white blood cells and platelets. The Company is also advancing both oral and topical pan-LOX inhibitors in scar prevention and scar modification programs. Its PXS-4728 is a SSAO/MAOB inhibitor to treat sleep disorders and slow progression of neurodegenerative diseases like Parkinson’s by reducing neuroinflammation. The Company’s other drug candidates target fibrotic and inflammatory diseases such as kidney fibrosis, NASH, pulmonary fibrosis, and cardiac fibrosis. It has developed two respiratory products: Bronchitol, for cystic fibrosis, and Aridol, a lung function test.More

Announcements

Filter Results

All Price Sensitive Only

Filters [Clear]

Price Sensitive: Yes

SNT	Pharmaxis Announces Milestone in Phase III Trial for CF	PRICE SENSITIVE	01/04/09	29.24KB	Share
SNT	Pharmaxis Appoints French Distributor for Aridol	PRICE SENSITIVE	11/03/09	27.4KB	Share
SNT	Aridol New Drug Application Submitted to FDA	PRICE SENSITIVE	02/03/09	28.48KB	Share
SNT	Half Yearly Report - December 2008	PRICE SENSITIVE	06/02/09	185.36KB	Share
SNT	Appendix 4C - quarterly	PRICE SENSITIVE	28/01/09	56.69KB	Share

SNTPharmaxis Announces Milestone in Phase III Trial for CF
01/04/09	PRICE SENSITIVE	29.24KB	Share
SNTPharmaxis Appoints French Distributor for Aridol
11/03/09	PRICE SENSITIVE	27.4KB	Share
SNTAridol New Drug Application Submitted to FDA
02/03/09	PRICE SENSITIVE	28.48KB	Share
SNTHalf Yearly Report - December 2008
06/02/09	PRICE SENSITIVE	185.36KB	Share
SNTAppendix 4C - quarterly
28/01/09	PRICE SENSITIVE	56.69KB	Share

REFRESH

First 2 3

(20min delay)
Last 2.4¢		Change 0.002(9.09%)		Mkt cap ! $28.65M

Open	High	Low	Value	Volume
2.2¢	2.5¢	2.2¢	$12.04K	509.9K

Buyers (Bids)

No.	Vol.	Price($)
1	82668	2.3¢

Sellers (Offers)

Price($)	Vol.	No.
2.4¢	100000	1

View Market Depth

No.	Vol.	Price($)
1	82668	0.023
2	338839	0.022
5	1736248	0.021
11	2801008	0.020
2	999988	0.019

Price($)	Vol.	No.
0.024	100000	1
0.025	100000	1
0.026	50000	1
0.027	200000	1
0.028	500000	1

Last trade - 15.57pm 28/06/2024 (20 minute delay)


Last 2.5¢		Change 0.002 ( 13.6 %)
Open	High	Low	Volume
2.2¢	2.5¢	2.2¢	478642
Last updated 15.53pm 28/06/2024 ?

SNT (ASX) Chart

SYNTARA LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories